Inicio \ Investigación \ Publicaciones científicas \


A Novel Prototype African Swine Fever Virus DIVA (Differentiation Between Infected and Vaccinated Animals) Serological Assay Based on the Detection of Antibodies Against the pEP153R, eGFP, and p72 Proteins

Investigación publicada en Vaccines

20 de febrero de 2025

Background/Objectives: African Swine Fever (ASF) is one of the most significant infectious diseases affecting both domestic pig and wild boar populations, leading to substantial economic and biosanitary consequences. In Europe, disease management relies on stringent biosecurity measures and surveillance through diagnosis, highlighting the urgent need for an effective and safe vaccine for ASF control. In this context, the VACDIVA project has generated several promising vaccine candidates, including those with the EP153R gene deleted and replaced by the eGFP reporter gene. Methods: In this study, pEP153R and eGFP proteins were produced using recombinant technology and demonstrated their antigenicity and DIVA capability through indirect ELISA. Additionally, a prototype serological DIVA test was designed and developed. The assay is based on the detection of antibodies against both DIVA antigens and the well-established immunogenic p72 protein. Results: This preliminary DIVA diagnostic assay complements vaccine candidates based on a genotype II ASFV strain, featuring the deletion of the EP153R gene and/or the insertion of the eGFP reporter gene, exemplified by the Lv17/WB/Rie1-?CD vaccine candidate. Conclusions: This approach could potentially improve surveillance during prospective vaccination campaigns




Gonzalez-Garcia G., Gallardo C., Monton M., Barroso-Arevalo S., Casado N., Barasona JA., Sanchez-Vizcaino JM., Venteo A., Sastre P. y Rueda P.




Ver artículo
A Novel Prototype African Swine Fever Virus DIVA (Differentiation Between Infected and Vaccinated Animals) Serological Assay Based on the Detection of Antibodies Against the pEP153R, eGFP, and p72 Proteins

Ver en NLM PubMed
A Novel Prototype African Swine Fever Virus DIVA (Differentiation Between Infected and Vaccinated Animals) Serological Assay Based on the Detection of Antibodies Against the pEP153R, eGFP, and p72 Proteins



Participantes:

Gold Standard DiagnosticsGold Standard Diagnostics.

Instituto Nacional de Investigación y Tecnología Agraria y AlimentariaEuropean Union Reference Laboratory for African Swine Fever. Centro de Investigación en Sanidad Animal (CISA). Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA).

Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas (CSIC).

Universidad ComplutenseServicio de Inmunología Viral y Medicina Preventiva (SUAT). Centro de Vigilancia Sanitaria Veterinaria (VISAVET). Universidad Complutense (UCM).

Universidad ComplutenseDepartamento de Sanidad Animal. Facultad de Veterinaria. Universidad Complutense (UCM).







Vaccines
FACTOR YEAR Q
5.200 2023

PMID: 40266072

ISSN: 2076-393X



TÍTULO: A Novel Prototype African Swine Fever Virus DIVA (Differentiation Between Infected and Vaccinated Animals) Serological Assay Based on the Detection of Antibodies Against the pEP153R, eGFP, and p72 Proteins


REVISTA: Vaccines


NUMERACIÓN: 13:3


AÑO: 2025


EDITORIAL: MDPI Basel


AUTORES: Gonzalez-Garcia G., Gallardo C., Monton M., Barroso-Arevalo S., Casado N., Barasona JA., Sanchez-Vizcaino JM., Venteo A., Sastre P. and Rueda P.


4th
Sandra Barroso Arévalo
6th
José Ángel Barasona García-Arévalo
7th
José Manuel Sánchez-Vizcaíno Rodríguez

DOI: https://doi.org/10.3390/vaccines13030211


CITA ESTA PUBLICACIÓN:

Gonzalez-Garcia G., Gallardo C., Monton M., Barroso-Arevalo S., Casado N., Barasona JA., Sanchez-Vizcaino JM., Venteo A., Sastre P. y Rueda P. A Novel Prototype African Swine Fever Virus DIVA (Differentiation Between Infected and Vaccinated Animals) Serological Assay Based on the Detection of Antibodies Against the pEP153R, eGFP, and p72 Proteins. Vaccines. 13:3. 2025. (A). ISSN: 2076-393X. DOI: 10.3390/vaccines13030211


SERVICIOS: